Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Market share of orphan drugs valued >$6,000 per year 2017, by therapy class

Market share of orphan drugs that cost patients more than $6,000 per year in 2017, by therapy class

by Statista Research Department, last edited Mar 7, 2019
Market share of orphan drugs valued >$6,000 per year 2017, by therapy class This statistic depicts the market share of orphan drugs that cost patients more than 6,000 U.S. dollars in 2017. In that year, oncology drugs costing more than 6,000 dollars per patient annually accounted for nearly 41 percent of the total orphan drug market.
Show more

Market share of orphan drugs that cost patients more than $6,000 per year in 2017, by therapy class

Percentage of orphan drug market
--
--
--
--
--
--
--
--
--
--
--
Percentage of orphan drug market
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Mar 7, 2019
This statistic depicts the market share of orphan drugs that cost patients more than 6,000 U.S. dollars in 2017. In that year, oncology drugs costing more than 6,000 dollars per patient annually accounted for nearly 41 percent of the total orphan drug market.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Orphan drugs"
  • Market overview
The most important statistics
  • Companies
  • Products
  • Research and development
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.